These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 3016233

  • 1. Radioimmunoassay for the quantitation of lisinopril and enalaprilat.
    Worland PJ, Jarrott B.
    J Pharm Sci; 1986 May; 75(5):512-6. PubMed ID: 3016233
    [Abstract] [Full Text] [Related]

  • 2. Pharmacodynamics and population pharmacokinetics of enalapril and lisinopril.
    Ajayi AA, Campbell BC, Kelman AW, Howie C, Meredith PA, Reid JL.
    Int J Clin Pharmacol Res; 1985 May; 5(6):419-27. PubMed ID: 3005181
    [Abstract] [Full Text] [Related]

  • 3. Differential renal handling of angiotensin-converting enzyme inhibitors enalaprilat and lisinopril in rats.
    Lin JH, Chen IW, Ulm EH, Duggan DE.
    Drug Metab Dispos; 1988 May; 16(3):392-6. PubMed ID: 2900730
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis.
    Kelly JG, Doyle GD, Carmody M, Glover DR, Cooper WD.
    Br J Clin Pharmacol; 1988 Dec; 26(6):781-6. PubMed ID: 2853960
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-proline.
    Bull HG, Thornberry NA, Cordes MH, Patchett AA, Cordes EH.
    J Biol Chem; 1985 Mar 10; 260(5):2952-62. PubMed ID: 2982845
    [Abstract] [Full Text] [Related]

  • 6. Regional haemodynamic effects of captopril, enalaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro rats.
    Muller AF, Gardiner SM, Compton AM, Bennett T.
    Clin Sci (Lond); 1990 Oct 10; 79(4):393-401. PubMed ID: 2171862
    [Abstract] [Full Text] [Related]

  • 7. Time-resolved fluoroimmunoassay for the determination of lisinopril and enalaprilat in human serum.
    Yuan AS, Gilbert JD.
    J Pharm Biomed Anal; 1996 May 10; 14(7):773-81. PubMed ID: 8809701
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A comparison of lisinopril with enalapril by monitoring plasma angiotensin II levels in humans.
    Kawamura M, Imanishi M, Matsushima Y, Akabane S, Kuramochi M, Ito K, Omae T.
    Jpn J Pharmacol; 1990 Oct 10; 54(2):143-9. PubMed ID: 1963909
    [Abstract] [Full Text] [Related]

  • 11. The effect of renal function on enalapril kinetics.
    Lowenthal DT, Irvin JD, Merrill D, Saris S, Ulm E, Goldstein S, Hichens M, Klein L, Till A, Harris K.
    Clin Pharmacol Ther; 1985 Dec 10; 38(6):661-6. PubMed ID: 2998676
    [Abstract] [Full Text] [Related]

  • 12. Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol.
    Bendtsen F, Henriksen JH.
    J Hum Hypertens; 1989 Jun 10; 3 Suppl 1():139-45. PubMed ID: 2550636
    [Abstract] [Full Text] [Related]

  • 13. Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.
    Hockings N, Ajayi AA, Reid JL.
    Br J Clin Pharmacol; 1986 Apr 10; 21(4):341-8. PubMed ID: 3011046
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Molecular mechanism for the relative binding affinity to the intestinal peptide carrier. Comparison of three ACE-inhibitors: enalapril, enalaprilat, and lisinopril.
    Swaan PW, Stehouwer MC, Tukker JJ.
    Biochim Biophys Acta; 1995 May 24; 1236(1):31-8. PubMed ID: 7794953
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Angiotensin converting enzyme inhibition in plasma and tissues.
    Johnston CI, Cubela R, Sakaguchi K, Jackson B.
    Clin Exp Hypertens A; 1987 May 24; 9(2-3):307-21. PubMed ID: 3038391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.